Pharmaceuticals

Increasing Awareness Of Personal Hygiene Fueling The Growth Due To Rising Concern Over Fungal Infections Is Supporting Expansion In The Quinolones Market

May 4, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Anticipated Rise In Market Value Of The Quinolones Market During The Forecast Period?

The quinolones market has shown consistent expansion in recent years. It is projected to expand from $51.89 billion in 2025 to $54.48 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 5.0%. This historical growth can be attributed to factors such as the increasing occurrence of bacterial infections, a rise in hospital admissions, significant demand for broad-spectrum antibiotics, the expansion of retail pharmacies, and governmental programs aimed at managing infectious diseases.

The quinolones market is projected to experience substantial expansion in the coming years. By 2030, this market is anticipated to reach a valuation of $66.44 billion, exhibiting a compound annual growth rate (CAGR) of 5.1%. This expansion during the projection period stems from factors such as progress in precision medicine, the creation of new quinolone formulations, the proliferation of online pharmacy platforms, heightened recognition of antimicrobial stewardship, and the growing utilization of digital health monitoring instruments. Key trends anticipated within the forecast timeframe involve enhanced management of antibiotic resistance, an increase in the availability of generic drugs, the adoption of personalized treatment strategies, an uptick in outpatient and home healthcare provisions, and greater funding for research and development into new quinolones.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9429&type=smp

What Key Factors Are Shaping The Quinolones Market Landscape?

The escalating threat of antimicrobial resistance is projected to fuel the expansion of the quinolones market moving forward. Antimicrobial resistance (AMR) signifies the capability of microorganisms, such as bacteria, viruses, parasites, and fungi, to resist the effects of antimicrobial drugs. Quinolones exhibit a broad spectrum of activity, making them effective against a diverse range of bacteria. They are prescribed for specific types of infections and can penetrate various tissues, making them a preferred choice when other options are limited. For example, in October 2025, a comprehensive global analysis by the World Health Organization, a US-based intergovernmental organization, investigated antibiotic resistance prevalence and trends. This analysis utilized data from over 23 million confirmed cases of bloodstream, urinary tract, and gastrointestinal infections, as well as urogenital gonorrhea. The insights were gathered from reports submitted by 104 countries in 2023. Thus, the rising peril of antimicrobial resistance is driving the growth of the quinolones market.

How Are Segments Identified Within The Quinolones Market Segment Framework?

The quinolones market covered in this report is segmented –

1) By Type: Norfloxacin, Ofloxacin, Ciprofloxacin, Gemifloxacin, Other Types

2) By Pathogen Type: Gram-Positive Pathogen, Gram-Negative Pathogen

3) By Application: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

What Market Trends Are Affecting The Quinolones Market?

Major corporations active in the quinolones market are increasingly concentrating on innovative offerings like fluoroquinolone antibiotic eye drops to boost their revenue streams. Fluoroquinolone antibiotic eye drops represent a class of antimicrobial agents specifically designed to treat bacterial infections affecting the eye. For instance, Harrow Health Inc., a US-based pharmaceutical firm, introduced Vigamox in July 2023. This solution is isotonic, with an osmolality of about 290 mOsm/kg, and contains 5.45 mg moxifloxacin hydrochloride, equivalent to 5 mg moxifloxacin base. The medication is presented in a 3-milliliter bottle and is dispensed as a sterile ophthalmic solution within a system featuring a tan polypropylene closure, a dispensing plug, and a natural low-density polyethylene bottle. Vigamox is recommended for prophylaxis against ocular infections both preceding and following surgical interventions.

Who Are The Companies Competing Within The Quinolones Market?

Major companies operating in the quinolones market are Bayer AG, Novartis AG, Sanofi SA, Merck & Co. Inc., LG Life Sciences, Pfizer Inc., Viatris Inc., Lupin Limited, Hikma Pharmaceuticals plc, Zydus Group, KYORIN Holdings Inc., Teva Pharmaceutical Industries Ltd., GSK plc, Zee Laboratories, Cipla Ltd., Geo Pharma Pvt. Ltd., Finecure Pharmaceuticals, AstraZeneca plc, Sun Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Cadila Healthcare Ltd., Glenmark Pharmaceuticals Ltd., Alkem Laboratories Ltd., Torrent Pharmaceuticals Ltd., Macleods Pharmaceuticals Ltd., Alembic Pharmaceuticals Ltd., Hetero Drugs Ltd., Wockhardt Ltd.

Get The Full Quinolones Market Report:

https://www.thebusinessresearchcompany.com/report/quinolones-global-market-report

Which Region Leads The Quinolones Market In Terms Of Market Share?

North America was the largest region in the quinolones market in 2025. The regions covered in the quinolones market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Quinolones Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/quinolones-global-market-report

Browse Through More Reports Similar to the Global Quinolones Market 2026, By The Business Research Company

Quinolones Market Report 2026

https://www.thebusinessresearchcompany.com/report/quinolones-global-market-report

Quinoa Market Report 2026

https://www.thebusinessresearchcompany.com/report/quinoa-global-market-report

Fluoxetine Market Report 2026

https://www.thebusinessresearchcompany.com/report/fluoxetine-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795